SCHEMBL572510

SCHEMBL572510

O=C(O)C1CCC(n2c(Nc3ccc(F)cc3)nc3ccc(CO)cc32)CC1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SPR P35270 2/20 0.59
▸ ALK Q9UM73 15/20 0.53
▸ BRD4 O60885 1/20 0.49
▸ CREBBP Q92793 1/20 0.49
▸ MAP3K7 O43318 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ NTRK1 P04629 1/20 0.44
▸ INSR P06213 1/20 0.44
▸ LCK P06239 1/20 0.44
▸ LTK P29376 1/20 0.44
▸ AXL P30530 1/20 0.44
▸ FLT3 P36888 1/20 0.44
▸ IRAK1 P51617 1/20 0.44
▸ MAP4K2 Q12851 1/20 0.44
▸ MERTK Q12866 1/20 0.44
▸ IDH1 O75874 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571730 0.91 SPR (0.51) SPRALKBRD4CREBBPMAP3K7
SCHEMBL572511 0.87 SPR (0.78) SPRALKMAP3K7IRAK4NTRK1
Hydrochloric Acid SCHEMBL572499 0.86 SPR (0.77) SPRALKNTRK1INSRLCK
Hydrochloric Acid SCHEMBL572500 0.86 SPR (0.77) SPRALKNTRK1INSRLCK
SCHEMBL572599 0.85 ALK (0.53) SPRALKBRD4CREBBPNTRK1
SCHEMBL572238 0.82 ALK (0.60) SPRALKBRD4CREBBPMAP3K7
SCHEMBL572239 0.82 ALK (0.60) SPRALKBRD4CREBBPMAP3K7
SCHEMBL571731 0.79 ALK (0.66) SPRALKMAP3K7IRAK4
SCHEMBL572884 0.78 SPR (0.44) SPRALKBRD4CREBBPMAP3K7
SCHEMBL571741 0.77 SPR (0.57) SPRALKIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611784-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE Amgen, Inc (US) 2013-07-10 — — EP disclosed
WO-2012018668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2012-02-09 — — WO disclosed
Send feedback